Table 2.
Characteristics of patients reported in the included studies
| Authors | Male, % | Age, years | BMI | Preoperative status | Pathology |
|---|---|---|---|---|---|
| Chan et al.18 | 58% | 71.5 (45–83)d | NR | NR | ACA of pancreas (n = 4), ACA of biliary tract (n = 2), CIS of biliary tract (n = 1), IPMN (n = 1), SCN (n = 1), NET (n = 1), SPN (n = 1), pseudocyst (n = 1) |
| Giulianotti et al.23 | 38% | 58 (25–86)c | NR | NR | PD: ACA of pancreas (n = 27), ACA of biliary tract (n = 17), MCN (n = 5), chronic pancreatitis (n = 5), duodenal pathology (n = 3), IPMN (n = 1), SPN (n = 1), choledochal cyst (n = 1) DP: non-malignant (n = 29), ACA of pancreas (n = 6), NET (n = 5), cystic NET (n = 2), MCN (n = 2), metastases (n = 2) |
| Kang et al.20 (DP) | R: 40% L: 44% | R: 44.5 ± 15.9 L: 56.5 ± 13.9b | R: 24.2 ± 2.9 L: 23.4 ± 2.6b | NR | R: MCN (n = 5), SCN (n = 4), SPN (n = 4), NET (n = 3), IPMN (n = 2), pancreatitis (n = 1), IPAS (n = 1) L: IPMN (n = 10), SPN (n = 4), SCN (n = 3), NET (n = 3), MCN (n = 2), pseudocyst (n = 1), IPAS (n = 1), benign stricture (n = 1) |
| Kang et al.21 (CP) | R: 0% O: 40% | R: 50.0 ± 12.3 O: 38.7 ± 16.5b | NR | NR | R: SPN (n = 4), NET (n = 1) O: SPN (n = 3), NET (n = 3), MCN (n = 3), congenital cyst (n = 1) |
| Narula et al.24 | NR | 51.6a | NR | NR | Chronic inflammation and fibrosis (n = 4), ACA (n = 1) |
| Waters et al.17 | R: 35% L: 50% O: 45% | R: 64 L: 59 O: 59a | NR | ASA: R: 2.8 L: 2.9 O: 2.9a | R: IPMN (n = 6), NET (n = 5), MCN (n = 3), SCN (n = 1), other (n = 2) L: NET (n = 5), MCN (n = 3), SCN (n = 2), ACA (n = 2), IPMN (n = 2), other (n = 3) O: ACA (n = 11), NET (n = 4), IPMN (n = 4), MCN (n = 2), other (n = 1) |
| Zeh et al.19 | 48% | 68 ± 16b | 27 ± 5b | ASA: II: 42.0% III: 56.0% IV: 2.0% | ACA of pancreas (n = 14), ACA of biliary tract (n = 11), NET (n = 10), IPMN (n = 10), SPN (n = 2), MCN (n = 1), duodenal adenoma (n = 1), oligocystic SCN (n = 1) |
| Zhou et al.22 | R: 62.5% O: 50.0% | R: 64.4 ± 9.1 O: 59.4 ± 9.4b | NR | NR | R: ACA of biliary tract (n = 6), ACA of pancreas (n = 1), periampullar ACA (n = 1) O: ACA of biliary tract (n = 4), pancreatic ACA (n = 2), papilloma of biliary tract (n = 1), duodenal papilloma (n = 1) |
a
Mean.
b
Mean ± standard deviation.
c
Mean (range).
d
Median (range).
BMI, body mass index; R, robot-assisted; L, laparoscopic; O, open; NR, not reported; ASA, American Society of Anesthesiologists; CP, central pancreatectomy; DP, distal pancreatectomy; PD, pancreatoduodenectomy; ACA, adenocarcinoma; CIS, carcinoma in situ; IPAS, intrapancreatic accessory spleen; IPMN, intraductal papillary mucinous neoplasm; MCN, mucinous cystic neoplasm; NET, neuroendocrine tumour; SCN, serous cystic neoplasm; SPN, solid pseudopapillary neoplasm.